Jesani, AmarCoutinho, Lester2019-09-252019-09-252011-03-132007-070975-5691http://hdl.handle.net/20.500.12424/176896"We discussed three major issues: (a) ethical concerns related to the collaborative relationship between IAVI as sponsor and Targeted Genetics, the producer of the candidate vaccine on one hand, and IAVI and its Indian collaborators on the other; (b) the issue of the patent of the candidate vaccine and whether there has been any specific agreement and institutional mechanism established for making the successful vaccine accessible to Indian people; and (c) the systematic indifference to investment in the development of a therapeutic vaccine for HIV/AIDSengWith permission of the license/copyright holderhealth ethicsmedical careBioethicsSocial ethicsSexual orientation/genderMedical ethicsHealth ethicsAIDS vaccine trials for IndiaArticle